T1	Participants 0 126	Double blind, placebo controlled study of metronidazole as a disease modifying agent in the treatment of rheumatoid arthritis.
T2	Participants 154 249	that metronidazole may have disease modifying activity in the treatment of rheumatoid arthritis
T3	Participants 305 366	comparative trial of metronidazole and placebo was performed.
T4	Participants 367 540	Fifty patients with active rheumatoid arthritis were randomly allocated to receive active drug (n = 24) or placebo (n = 26) and reviewed at weeks 0, 1, 4, 8, 12, 16, and 24.
